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also demonstrated that partial inhibition of 
Vif can lead to drug-resistant HIV strains 
due to hypermutation10. Furthermore, 
chronic infection with HIV is associated with 
a specific defect in NKG2D-mediated activa-
tion of NK cells due to lower expression of 
NKG2D11. This lower NKG2D expression 
is associated with higher concentrations of 
MICA, the soluble form of the NKG2D-L, 
in serum from HIV-infected patients. Thus, 
HIV may indirectly suppress the recognition 
of HIV-infected CD4+ T cells by NK cells by 
enhancing the secretion of NKG2D-L into 
the serum, which results in profound impair-
ment of NK cell function. These factors 
will have to be considered in the design of 
Vif antagonists.
drug targets9. Inhibition of Vif-APOBEC3G 
interactions has been shown to restrict HIV 
infection through the mutation and deg-
radation of uracil-containing viral DNA. 
Targeting Vif-APOBEC3G interactions 
may have additional therapeutic benefits 
by rendering HIV-infected cells sensitive 
to NK cell–mediated lysis2. Combining the 
administration of small molecules that inter-
fere with Vif with simultaneous NK cell–acti-
vation protocols or infusion of NK cells may 
further potentiate the antiviral effects of the 
small molecules. The administration of type 
I interferons, which enhance NK cell activ-
ity, may have the added benefit of increasing 
APOBEC3G expression and inducing other 
antiviral activities. However, studies have 
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T cell tolerance is essential to the prevention of autoimmunity. The ubiquitin E3 ligase Peli1 acts as a negative 
regulator of T cell activation and contributes to the maintenance of self-tolerance.
mice show hyperactivation and greater prolifer-
ative responses to TCR-CD28 signaling. These 
cells are also less susceptible to anergy and sup-
pression by regulatory T cells (Treg cells). Aging 
Peli1–/– mice also have a greater frequency and 
number of memory T cells but a lower fre-
quency of naive cells. These mice have enlarged 
peripheral lymph nodes and substantial tissue 
infiltration by cells of the immune response. 
Peli1–/– mice show distinct signs of spontane-
ous autoimmunity with age, as demonstrated 
by the detection of serum antinuclear autoan-
tibodies and prominent deposition of immune 
complexes in the kidney. Furthermore, T cells 
from Peli1–/– mice show more pathogenic 
potential in experimental autoimmune enceph-
alomyelitis, an inducible autoimmune model of 
multiple sclerosis. All these findings suggest a 
T cell–intrinsic role for Peli1 in negatively 
regulating T cell signaling, facilitating self- 
tolerance and protecting against autoimmunity. 
An elegant mechanistic explanation for these 
effects is provided by the identification of c-Rel 
as a Peli1 target2. Signaling by TCR and CD28 
together induces Peli1 expression, which leads 
to its interaction with and polyubiquitination 
of c-Rel, resulting in degradation of the latter 
(Fig. 1). Loss of Peli1 thus leads to late-phase 
hyperactivation and nuclear accumulation 
of c-Rel in response to TCR-CD28 signaling 
and given the role of c-Rel in promoting the 
activation, proliferation and differentiation of 
NF-κB is one of the most critical outcomes of 
this costimulation3. Lack of NF-κB is associated 
with immune deficiencies, whereas abnormal 
activation of NF-κB is associated with autoim-
munity and cancer. The NF-κB family consists 
of five Rel proteins that can form dimers in 
various combinations to regulate gene tran-
scription. In most resting cells, dimeric NF-κB 
complexes are sequestered in the cytoplasm 
by inhibitory IκB proteins. Innate immune 
receptor systems such as Toll-like receptors 
(TLRs) engage adaptor proteins such as MyD88 
and TRIF to trigger activation of an IκB kinase 
complex that catalyzes the phosphorylation of 
IκB proteins, thus promoting their degradation 
by the proteasome. Liberated NF-κB translocates 
to the nucleus and drives the transcription 
of genes that encode proinflammatory mol-
ecules. In T cells, the simultaneous signaling 
of TCR and CD28 also strongly stimulates 
the IκB kinase complex, activates NF-κB and 
induces CD28-responsive genes such as those 
encoding interferon-γ and interleukin 2 (IL-2), 
which drive the activation and proliferation of 
T cells3 (Fig. 1). Robust costimulation by TCR-
CD28 leads to strong T cell activation, whereas 
engagement of the TCR in the absence of CD28 
costimulation results in T cell anergy.
Chang et al. now identify Peli1 as a mediator 
of the anergic process that acts as a negative 
regulator of TCR-CD28 signaling2. CD4+ and 
CD8+ T cells from Peli1-deficient (Peli1–/–) 
The immune system has an amazing capacity to discriminate between self and non-self 
while also being able to recognize a bewilder-
ing array of foreign chemical entities. This is 
made possible by the diverse receptor reper-
toire of lymphocytes. In the thymus, T cells that 
express high-affinity receptors for self antigens 
are eliminated. Some T cells, which express 
low-affinity receptors for self antigens or with 
receptors for antigens that do not reach the thy-
mus for presentation, escape thymic deletion 
and are released into the periphery. A critical 
peripheral tolerance mechanism that prevents 
these self-reactive T cells from triggering auto-
immune responses includes the induction of 
a state of unresponsiveness known as ‘T cell 
anergy’1. In this issue of Nature Immunology, 
Chang et al. identify the ubiquitin E3 ligase 
Peli1 as a key negative regulator of T cell activa-
tion, with deficiency in Peli1 being associated 
with loss of self-tolerance and the manifesta-
tion of spontaneous autoimmunity2.
Full activation of a T cell requires two sig-
nals. The first signal is provided by the T cell 
antigen receptor (TCR), and the second is 
provided by a costimulatory receptor such as 
CD28. Activation of the transcription factor 
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Figure 1  Peli1 negatively regulates T cell signaling by targeting c-Rel. Costimulation of CD28 and 
the CD3 subunit of the TCR complex in CD4+ or CD8+ T cells triggers a complex series of membrane 
proximal signaling events that culminate in activation of the IκB kinase (IKK) complex. This complex 
subsequently phosphorylates IκB, leading to its degradation and the release of Rel subunits of the 
NF-κB family. It is also possible that Rel subunits may be activated by IκB kinase–independent 
mechanisms3. Free c-Rel translocates to the nucleus and binds to the CD28-responsive region of  
genes such as Il2, leading to more transcription. IL-2 is a mitogenic factor for T cells and promotes  
T cell proliferation. The TCR-CD28 pathway can also induce expression of Peli1 by an uncharacterized 
pathway. Peli1 interacts with c-Rel and catalyzes its polyubiquitination (Ub), which results in 
degradation of c-Rel by the proteasome. This inhibits the induction of cytokines such as IL-2 and 
results in a state of unresponsiveness known as ‘T cell anergy’ that is associated with peripheral T cell 






























The Chang et al. study also highlights key 
differences in the function of Peli proteins in 
the innate and adaptive immune systems2. 
Although Peli1 is able to promote polyubiq-
uitination and degradation of a target protein 
in T cells, published studies of Peli proteins 
have focused on their function in the TLR–
IL-1 pathways in the innate immune system 
and have highlighted their tendency to cata-
lyze polyubiquitination of signaling molecules 
such as IRAK and RIP1, leading to regulation 
of protein function rather than degradation5,6. 
This raises the question of how Peli proteins 
can be regulated in different ways and directed 
toward the catalysis of different types of poly-
ubiquitination with various functional out-
comes. In TLR pathways, the E3 ligase activity 
of Peli proteins can be increased by various 
kinases7,8, and it will be interesting to deter-
mine if the activity of Peli1 is subject to regu-
lation by TCR-CD28 signaling. Furthermore, 
Peli1 seems to be able to manifest contrasting 
effects in different cell settings. Thus, Peli1 
negatively regulates the activation of c-Rel by 
TCR-CD28 (ref. 2), whereas it mediates TRIF-
dependent activation of NF-κB in some TLR 
pathways by acting as an E3 ubiquitin ligase 
for RIP1 (ref. 6). The latter function of Peli1 
translates into an important role in mediating 
the TLR3-induced activation of B cells. This 
raises the fundamental question of why the 
same molecule would be used to negatively 
regulate T cell activation but strongly activate 
B cells and how such opposing functions are 
controlled. Further hints of the dichotomy of 
Peli1 function in the innate and adaptive sys-
tems also emerge from its different roles in 
mediating responses to TGF-β. Thus, Peli1 
facilitates TGF-β-mediated suppression of 
T cell activation2, whereas TGF-β represses 
inflammatory IL-1 signaling by using the sig-
nal transducer Smad6 to inhibit the interac-
tion of Peli1 with IRAK1 in the IL-1 pathway9. 
However, the importance of Peli1 as a target of 
TGF-β in the IL-1 pathway is equivocal, given 
that cells from Peli1-deficient mice have an 
intact IL-1 signaling pathway6.
The study presented in this issue2 adds Peli1 
to a growing number of E3 ligases that regulate 
T cell tolerance. Cbl-b and Itch are E3 ligases 
that, like Peli1, negatively regulate T cell acti-
vation and promote tolerance10. Whereas Peli1 
inhibits c-Rel, a late downstream mediator of 
T cell signaling, Cbl-b and Itch target mole-
cules that are more proximal to the TCR-CD28 
signaling complex. Such tight regulation 
of T cell activation at various levels of the sig-
naling pathway is presumably an attempted 
fail-safe  against loss of self-tolerance and auto-
immune disease. E3 ubiquitin ligases are 
emerging to the fore in this process, and the 
development of Treg cells while facilitating the 
suppressor effects of Treg cells and its effec-
tor cytokine TGF-β on T cell activation. The 
role of Peli1 in the latter is probably dominant, 
given the spontaneous autoimmunity that is 
apparent in Peli1–/– mice2. It is also intriguing 
that the negative effects of Peli1 on TCR-CD28 
signaling seem to be confined to peripheral 
T cells. Although strong TCR-CD28 signal-
ing is required for the activation of T cells in 
the periphery, one of the key central tolerance 
mechanisms used in the thymus is the deletion 
of autoreactive T cells by self antigen–induced 
TCR-CD28 signaling1. It might be possible that 
loss of Peli1 may also lead to stronger TCR-
CD28 signaling in self-reactive cells that might 
normally escape thymic deletion because of 
weak activation by low-affinity antigens. Such 
a scenario would lead to more efficient deletion 
of autoreactive T cells in the thymus and dimin-
ish the likelihood of autoimmunity. However, 
Peli1–/– mice develop spontaneous autoim-
munity instead, which again emphasizes the 
prominent role of Peli1 in peripheral T cells.
T cells, this is a very plausible basis for the loss 
of self-tolerance and spontaneous autoimmu-
nity in Peli1-deficient mice.
It is especially interesting that the regulatory 
role of Peli1 shows some degree of cell speci-
ficity, in that the effects of Peli1 deficiency are 
greater in CD8+ T cells than in CD4+ T cells2. 
All nucleated cells can express major histocom-
patibility complex class I and present antigen 
to CD8+ T cells, so the potential for activation 
of self-reactive CD8+ T cells is especially high. 
It is reassuring from a self-tolerance perspec-
tive that these cells have a strong regulator such 
as Peli1 that can temper cell activation. Given 
the spontaneous autoimmunity phenotype of 
Peli1-deficient mice, it is perhaps surprising 
that these mice have slightly more Treg cells in 
the thymus and periphery. However, the Peli1–
c-Rel relationship may provide an explanation, 
as c-Rel acts an important driver of the thymic 
development of Treg cells by directly promoting 
transcription of the gene encoding the signa-
ture Treg cell transcription factor Foxp3 (ref. 4). 
Paradoxically, Peli1 may negatively regulate the 
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malignancies3, it will be very interesting to 
determine if the Peli proteins are also involved 
in the cancer arena. In summary, the study by 
Chang et al. indicates Peli1 is a crucial regulator 
of T cell activation and autoimmunity2, which 
represents an exciting discovery that adds to 
the molecular understanding of the regulatory 
mechanisms that underlie self-tolerance.
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generation of knockout models will aid in 
determining whether the other Peli proteins, 
Peli2 and Peli3, regulate T cell tolerance. 
Interestingly, Peli2 interacts with Bcl-10, a key 
intermediate signaling molecule in the TCR-
CD28 pathway11.
Finally, the findings of Chang et al.2 justify 
population studies to explore the role of Peli1 in 
human autoimmune disease. Any Peli1 muta-
tions that affect its function and/or expres-
sion will probably to lead to autoimmunity. 
Furthermore, given that Peli1 effects c-Rel deg-
radation and c-Rel is associated with lymphoid 
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The innate immune system has evolved a series of cellular sensors and signaling path-
ways that activate host-defense mechanisms in 
response to microbial invasion1. However, how 
cells detect pathogens that contain double-
stranded DNA (dsDNA), such as many types 
of cancer-causing viruses, intracellular bacteria 
and perhaps parasites, remains to be resolved. 
In this report, Zhang et al. identify the DExDc 
helicase family member DDX41 as a sensor of 
cytosolic DNA that can trigger the produc-
tion of host antipathogen genes such as those 
that encode type I interferons in myeloid den-
dritic cells (DCs)2. The finding has potentially 
important implications for the understanding 
of innate immune processes, microbe-based 
pathogenesis and even autoimmune disease.
Interestingly, DDX41 is not the first DExDc 
helicase to be linked to the sensing microbial 
invasion and rapid facilitation of appropriate 
host-defense countermeasures. For example, 
the RNA helicases RIG-I, Mda5 and LGP2 are 
critically important for the detection of invad-
ing RNA viruses in almost all cells and for trig-
gering the production of antiviral proteins3. 
The RIG-I family and DDX41 are cytosolic 
DExD/H proteins that directly associate with 
pathogen-derived nucleic acid released into the 
cytosol. RIG-I recognizes 5′-triphosphorylated 
double-stranded RNA (dsRNA), which is 
STInG-dependent signaling
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The sensing of pathogen-associated DNA in the cytoplasm is an important trigger of host-defense responses that 
include the production of type I interferon. A new study suggests that the DExDc helicase DDX41 may function in 
dendritic cells as a DNA sensor to activate STING-dependent innate immune responses.
commonly produced by negative-stranded 
RNA viruses, whereas Mda5 recognizes larger, 
high-molecular-weight dsRNA species typically 
encoded by positive-stranded viruses4. The 
interaction of viral RNA with RIG-I and Mda5 
induces a conformational change that enables 
inter action with the mitochondrial adaptor 
IPS-1 (also known as MAVS, CARDIF or VISA), 
which facilitates the activation of transcription 
factors (such as IRF3, IRF7 and NF-κB) that 
are responsible for inducing the transcription 
of many genes encoding molecules important 
for host defense, including type I interferon1,5. 
Zhang et al. show that DDX41 interacts with 
dsDNA species, including the genomes of 
DNA viruses such as vaccinia virus and herpes 
simplex virus type 1 (HSV-1)2. This event, 
described in myeloid DCs, similarly leads to the 
production of type I interferon via activation of 
IRF3 and NF-κB (Fig. 1), although it requires the 
assistance of the transmembrane-containing, 
endoplasmic reticulum–associated adaptor 
STING (‘stimulator of interferon genes’)6. 
STING has been shown to be essential for the 
production of type I interferon by cytosolic 
dsDNA in nearly all cells examined, including 
mouse embryonic fibroblasts, macrophages 
and DCs. Accordingly, loss of STING prevents 
the production of type I interferon in response 
to transfected plasmids, DNA viruses and 
certain intracellular bacteria, such as Listeria 
monocytogenes and possibly even parasites. 
Mice that lack STING are viable but extremely 
sensitive to lethal infection with HSV-1. Thus, 
the STING-regulated pathway is extremely 
important for host defense against DNA- 
based microbes.
There are approximately 59 members of the 
DExD/H family; Zhang et al. identify DDX41 
by means of an RNA-mediated interference 
screen to individually suppress the expression 
of each of these helicases in cells2. They then 
assay the ability of such cells to produce type I 
interferon in response to cytosolic B-form DNA 
(poly(dA:dT)). They find that the suppression 
of DDX41 expression in DCs and monocytes 
impedes the transcription of type I interferons 
and cytokines such as interleukin 6 and tumor 
necrosis factor by dsDNA and HSV-1, similar 
to the loss of STING. HSV-1 replication is con-
comitantly greater in cells in which DDX41 is 
suppressed. Loss of DDX41, however, does not 
affect dsRNA-dependent production of type I 
interferons, which indicates specificity for the 
cytosolic DNA–dependent innate signaling 
pathway. Loss of DDX41 also does not affect 
the production of interleukin-1β by cytosolic 
DNA, which indicates that this helicase acts 
independently of the pathway for the produc-
tion of proinflammatory cytokines dependent 
on the cytoplasmic DNA receptor AIM2 and 
mediated by caspase-1 (ref. 7).
As additional experiments by this group 
indicate that the DEADc box of DDX41 can 
bind dsDNA (Z-form and B-form) but not 
synthetic ssRNA such as poly(U)2, these 
data collectively suggest that DDX41 asso-
ciates with dsDNA species from pathogens 
and subsequently recruits STING for the 
activation of type I interferons. Published 
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